No abstract available
MeSH terms
-
Angioedema / blood
-
Angioedema / immunology*
-
Angioedema / pathology
-
Angioedema / virology
-
Angiotensin-Converting Enzyme 2
-
Anti-Inflammatory Agents / pharmacology
-
Anti-Inflammatory Agents / therapeutic use
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / immunology*
-
Biomarkers / blood
-
COVID-19
-
COVID-19 Drug Treatment
-
COVID-19 Testing
-
Clinical Laboratory Techniques / methods
-
Congresses as Topic
-
Coronavirus Infections / blood
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / immunology*
-
Cytokine Release Syndrome / blood
-
Cytokine Release Syndrome / immunology*
-
Cytokine Release Syndrome / virology
-
Cytokines / antagonists & inhibitors
-
Cytokines / blood
-
Cytokines / immunology
-
Cytokines / metabolism*
-
Humans
-
Internet
-
Kallikrein-Kinin System / drug effects
-
Kallikrein-Kinin System / immunology
-
Pandemics
-
Peptidyl-Dipeptidase A / metabolism
-
Pneumonia, Viral / blood
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / immunology*
-
Pulmonary Alveoli / immunology
-
Pulmonary Alveoli / pathology
-
SARS-CoV-2
-
Severity of Illness Index
-
Signal Transduction / drug effects
-
Signal Transduction / immunology
-
Spike Glycoprotein, Coronavirus / immunology
-
Spike Glycoprotein, Coronavirus / metabolism
-
Time Factors
-
Time-to-Treatment
Substances
-
Anti-Inflammatory Agents
-
Antiviral Agents
-
Biomarkers
-
Cytokines
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2